Acadia Healthcare (NASDAQ:ACHC) Lifted to “Hold” at Deutsche Bank Aktiengesellschaft

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “sell” rating to a “hold” rating in a research report issued on Thursday, FinViz reports. The brokerage currently has a $70.00 price objective on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential downside of 1.67% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Monday, March 4th. TD Cowen increased their price target on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Mizuho increased their price target on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a research report on Wednesday, March 6th. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective for the company in a research note on Friday, January 5th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $92.00.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $71.19 on Thursday. The stock’s 50-day moving average is $78.68 and its 200-day moving average is $77.72. Acadia Healthcare has a 1-year low of $66.49 and a 1-year high of $87.77. The stock has a market cap of $6.58 billion, a P/E ratio of -284.75, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. During the same period in the previous year, the firm earned $0.70 earnings per share. The company’s revenue was up 10.0% compared to the same quarter last year. Equities research analysts anticipate that Acadia Healthcare will post 3.57 earnings per share for the current year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.80% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Exchange Traded Concepts LLC purchased a new position in shares of Acadia Healthcare during the third quarter worth about $549,000. Handelsbanken Fonder AB grew its holdings in shares of Acadia Healthcare by 16.3% during the third quarter. Handelsbanken Fonder AB now owns 14,274 shares of the company’s stock worth $1,004,000 after purchasing an additional 2,000 shares in the last quarter. Raymond James & Associates grew its holdings in shares of Acadia Healthcare by 0.6% during the third quarter. Raymond James & Associates now owns 76,048 shares of the company’s stock worth $5,347,000 after purchasing an additional 424 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Acadia Healthcare by 1.1% during the third quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock worth $88,482,000 after purchasing an additional 13,765 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Acadia Healthcare by 20.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,920 shares of the company’s stock worth $1,330,000 after buying an additional 3,167 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.